Galderma Settles Pimple Drug Patent Suit With Par

Law360, Washington (May 17, 2013, 5:35 PM EDT) -- Swiss skincare company Galderma SA and Par Pharmaceutical Inc. told a Texas federal court Friday they had reached a settlement over allegations that the generics maker sought to market a knockoff of Galderma's Epiduo acne treatment.

The companies asked the court to stay the case as they finalize their settlement agreement and prepare a motion to dismiss the suit.

“The parties expect to jointly file a motion to dismiss this action within the next 30 days,” the motion said. “Accordingly, the parties jointly move to stay...
To view the full article, register now.